Recent Activity
2026-09-26FR-BT-0004Normal Record Review admitted Sasieni et al. NEJM doi:10.1056/NEJMoa2505723 as IN-007 and Neal et al. Nature Medicine doi:10.1038/s41591-026-04652-8 as IN-008. These were held outside LPR-001-D28 until normal review.Fragmenting
2026-09-26FR-BT-0005Riella et al., Lancet 2026, admitted as IN-008 after being held outside LPR-001-D29. IN-003 retained as historical chronology rather than overwritten.Escalating
2026-09-23FR-BT-0001Normal Record Review of Bian et al. (2026), EBioMedicine 124:106124, DOI 10.1016/j.ebiom.2026.106124. The primary study reports D+Q effects in streptozotocin-induced diabetic male C57BL/6J mice and supporting cell models; it is admitted as disease-specific preclinical evidence. It reports no new human intervention result or hard human healthspan outcome. AS-003 is appended with no state change: ESCALATING / VS-02 retained. The review is separate from LPR-001-D25 and does not alter its provenance-correction outcome.Escalating
Evidence Trajectories - PROG-BT
View Biotechnology & Life Sciences trajectoriesBT records are brought forward within the full archive.Frontier Records — PROG-BT
FR-BT-0001Senolytic Therapies — Meaningful Human Healthspan ExtensionEscalating3 assessments2024-01-15FR-BT-0002Epigenetic Reprogramming — Biological Age Reversal Without Identity LossEscalating4 assessments2024-01-15FR-BT-0003Biological Age Biomarker Panels — Predictive Validity for Age-Related DeclineFragmenting3 assessments2024-01-15FR-BT-0004Liquid Biopsy — Early Cancer Detection Before Conventional DiagnosisFragmenting3 assessments2024-01-15FR-BT-0005Gene-Edited Porcine Kidneys — Durable Human Renal ReplacementEscalating2 assessments2026-08-21FR-BT-0006Bottom-Up Synthetic Cells — Autonomous Cellular ReproductionEmerging1 assessment2026-09-12FR-BT-0007Implantable Brain–Computer Interfaces — Sustained Communication in ParalysisEmerging1 assessment2026-09-15
No current programme-level diagnosis.